Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Parexel study highlights growing role of adaptive trials

Parexel study highlights growing role of adaptive trials

26th April 2011

Parexel has published data from a new industry survey which shows the growing role played by adaptive trials in the drug development sector.

Conducted by Parexel's Perceptive Informatics division, the poll of more than 300 global biopharmaceutical industry professionals showed that 80 percent of respondents are considering implementing some type of adaptive design in the next year.

According to the company, it is seeking to support this trend through its eClinical solutions offering, which provides services such as electronic data capture and electronic patient reported outcomes for studies of this kind.

Damian McEntegart, senior director of statistics and product support at Perceptive Informatics, said: "We are focused on helping the industry to successfully implement adaptive trials, which can enable better decision-making about compounds and reduce the time between development phases."

Earlier this month, Perceptive Informatics expanded its range of clinical trial management services through the launch of its new DataLabs 5.0 Electronic Data Capture system.ADNFCR-8000103-ID-800511580-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.